NEA Management Company »

Acrivon Therapeutics shares owned by NEA Management Company

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by NEA Management Company from 13F filings

Historical chart of NEA Management Company investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by NEA Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by NEA Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.3M 430k 2.99
2023-09-30 $4.1M 430k 9.56
2023-06-30 $6.2M 482k 12.96
2023-03-31 $4.9M 482k 10.15
2022-12-31 $4.4M 482k 9.22